Despite this, a GWAS involving clinically diagnosed late-onset AD patients found that variations in PPARG, the gene encoding the TZD target protein, were associated with a trend toward reduced odds of developing AD [317]. The gene discussed is PPARG; the disease is Alzheimer disease.